Your browser doesn't support javascript.
loading
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Crippa, José Alexandre S; Pacheco, Julia Cozar; Zuardi, Antonio W; Guimarães, Francisco S; Campos, Alline Cristina; Osório, Flávia de Lima; Loureiro, Sonia Regina; Dos Santos, Rafael G; Souza, José Diogo S; Ushirohira, Juliana Mayumi; Ferreira, Rafael Rinaldi; Mancini Costa, Karla Cristinne; Scomparin, Davi Silveira; Scarante, Franciele Franco; Pires-Dos-Santos, Isabela; Mechoulam, Raphael; Kapczinski, Flávio; Fonseca, Benedito A L; Esposito, Danillo L A; Passos, Afonso Dinis Costa; Dal Fabbro, Amaury Lelis; Bellissimo-Rodrigues, Fernando; Arruda, Eurico; Scarpelini, Sandro; Andraus, Maristela Haddad; Nather Junior, Julio Cesar; Wada, Danilo Tadao; Koenigkam-Santos, Marcel; Santos, Antonio Carlos; Busatto Filho, Geraldo; Hallak, Jaime E C.
Afiliación
  • Crippa JAS; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Pacheco JC; National Institute for Science and Technology-Translational Medicine, São Paulo, Brazil.
  • Zuardi AW; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Guimarães FS; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Campos AC; National Institute for Science and Technology-Translational Medicine, São Paulo, Brazil.
  • Osório FL; National Institute for Science and Technology-Translational Medicine, São Paulo, Brazil.
  • Loureiro SR; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Dos Santos RG; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Souza JDS; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Ushirohira JM; National Institute for Science and Technology-Translational Medicine, São Paulo, Brazil.
  • Ferreira RR; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Mancini Costa KC; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Scomparin DS; National Institute for Science and Technology-Translational Medicine, São Paulo, Brazil.
  • Scarante FF; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Pires-Dos-Santos I; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Mechoulam R; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Kapczinski F; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Fonseca BAL; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Esposito DLA; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Passos ADC; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Dal Fabbro AL; Department of Medicinal Chemistry and Natural Products, The Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Bellissimo-Rodrigues F; National Institute for Science and Technology-Translational Medicine, São Paulo, Brazil.
  • Arruda E; Department of Psychiatry and Behavioural Neurosciences, McMaster University and St. Joseph's Healthcare Hamilton, Hamilton, Canada.
  • Scarpelini S; Graduate Program in Psychiatry and Behavioral Sciences, Department of Psychiatry, Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
  • Andraus MH; Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Nather Junior JC; Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Wada DT; Department of Social Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Koenigkam-Santos M; Department of Social Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Santos AC; Department of Social Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Busatto Filho G; Department of Cell and Molecular Biology, and Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Hallak JEC; Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Cannabis Cannabinoid Res ; 7(5): 658-669, 2022 10.
Article en En | MEDLINE | ID: mdl-34619044
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabidiol / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Cannabis Cannabinoid Res Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabidiol / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Cannabis Cannabinoid Res Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos